By Professor Monica M. Lahra

Journal articles

George CRR; Varadhan H; Naqvi S; Locker B; Howes M; van Hal S; Lahra MM, 2025, 'Invasive Urogenital Neisseria meningitidis Serogroup Y Multilocus Sequence Type 1466', Emerging Infectious Diseases, 31, pp. 2067, http://dx.doi.org/10.3201/eid3110.250902

Lan PT; Phan Nguyen TT; Anh VT; Golparian D; Thuy Van NT; Maatouk I; Unemo M; Doanh LH; Lan PT; Hoa PQ; Hoa PD; Minh Phuong PT; Trang TM; Dieu Van TT; Nam PT; Ha Vinh NT; Ha Giang QT; Tung VT; Tuan ND; Thuy HP; Thach Lam TH; Thanh Nguyen PT; Doung BH; Van Loi Doan E; Le KT; Bui TM; Pham NN; Kieu Nguyen TT; Quynh Dang AD; Uyen Pham NT; Doan Vo PT; Nguyen TD; Kieu Hoang TM; Ngoc Nguyen QT; Nguyen HT; Anh VT; An NH; Van Dung T; Binh NT; Lahra M; Khoa NT; Maatouk I; Wi T; Golparian D; Schröder D; Jacobsson S; Unemo M, 2025, 'The World Health Organization (WHO) Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) reports continuously high levels of ceftriaxone resistance across Viet Nam, 2024', Lancet Regional Health Western Pacific, 63, http://dx.doi.org/10.1016/j.lanwpc.2025.101709

Unemo M; Lahra MM; Cole MJ; Marcano Zamora D; Jacobsson S; Galarza P; Martin I; Kreisel KM; Galas M; Bertagnolio S; Ramon-Pardo P; Maatouk I; Wi T, 2025, 'WHO global gonococcal antimicrobial surveillance programmes, 2019–22: a retrospective observational study', Lancet Microbe, 6, http://dx.doi.org/10.1016/j.lanmic.2025.101181

Maatouk I; Vumbugwa P; Cherdtrakulkiat T; Heng LS; Hoffman I; Palaypayon N; Kakooza F; Kittiyaowamarn R; Kyambadde P; Lahra MM; Lan PT; Maseko V; Matoga M; Machiha A; Müller E; Nguyen TTP; Doanh LH; Ouk V; Setiawaty V; Sia SB; Hartono TS; Virak M; Thuy Van NT; Unemo M; Wi T, 2025, 'Antimicrobial resistance in Neisseria gonorrhoeae in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational study', Lancet Regional Health Western Pacific, 61, http://dx.doi.org/10.1016/j.lanwpc.2025.101663

Lahra MM; Van Hal S; Hogan TR, 2025, 'Australian Gonococcal Surveillance Program, 1 October to 31 December 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.036

Lahra MM; Hogan TR, 2025, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2025', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.045

Lahra MM; Hogan TR, 2025, 'Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.039

Lahra MM; van Hal S; Hogan TR, 2025, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.018

Lahra MM; van Hal S; Hogan TR, 2025, 'Australian Gonococcal Surveillance Programme Annual Report, 2023', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.007

Lahra MM; Hogan TR, 2025, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.017

Lahra M; Van Hal S; Hogan T, 2025, 'Australian Gonococcal Surveillance Program, 1 January to 31 March 2025', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.046

Lahra MM; van Hal S; Hutabarat SN; Hogan TR, 2025, 'Australian Gonococcal Surveillance Program, 1 April to 30 June 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.002

Lahra MM; van Hal S; Hutabarat SN; Hogan TR, 2025, 'Australian Gonococcal Surveillance Program, 1 January to 31 March 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.001

Lahra MM; Hutabarat SN; van Hal S; Hogan TR, 2025, 'Erratum: Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.008

van Hal SJ; Lahra MM; Whiley DM, 2025, 'Determining targets for ceftriaxone resistance detection in Neisseria gonorrhoeae based on genotype–phenotype data: an observational study', Lancet Microbe, http://dx.doi.org/10.1016/j.lanmic.2025.101199

van Hal SJ; Le T; Jenkins F; Kundu RL; Limnios EA; McNamara LA; Sharma S; Kersh EN; Lahra MM, 2025, 'Neisseria meningitidis Serogroup Y Sequence Type 1466 and Urogenital Infections', Emerging Infectious Diseases, 31, pp. 86 - 93, http://dx.doi.org/10.3201/eid3101.240940

Williams PCM; Mostaghim M; Harrison J; Lahra M; Greenhalgh M; O'Sullivan M; Maley M; Oei J-L; Koirala A; Popat H; Lui K; McMullan B; Palasanthiran P; Kesson A; Isaacs D; Bartlett AW, 2025, 'Epidemiology of early-onset and late-onset invasive infections in Australian neonates and infants: a retrospective multicentre study.', BMJ Public Health, 3, pp. e002733, http://dx.doi.org/10.1136/bmjph-2025-002733

Lahra MM; George CRR; van Hal S; Hogan TR, 2024, 'Australian Meningococcal Surveillance Programme Annual Report, 2023', Communicable Diseases Intelligence 2018, 48, http://dx.doi.org/10.33321/cdi.2024.48.52

Lahra MM; Hutabarat SN; Hogan TR, 2024, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2024', Communicable Diseases Intelligence 2018, 48, http://dx.doi.org/10.33321/cdi.2024.48.54

Lahra MM; Hutabarat SN; Hogan TR, 2024, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2024', Communicable Diseases Intelligence 2018, 48, http://dx.doi.org/10.33321/cdi.2024.48.53

Bertagnolio S; Dobreva Z; Centner CM; Olaru ID; Donà D; Burzo S; Huttner BD; Chaillon A; Gebreselassie N; Wi T; Hasso-Agopsowicz M; Allegranzi B; Sati H; Ivanovska V; Kothari KU; Balkhy HH; Cassini A; Hamers RL; Weezenbeek KV; Aanensen D; Alanio A; Alastruey-Izquierdo A; Alemayehu T; Al-Hasan M; Allegaert K; Al-Maani AS; Al-Salman J; Alshukairi AN; Amir A; Applegate T; Araj GF; Villalobos MA; Årdal C; Ashiru-Oredope D; Ashley EA; Babin FX; Bachmann LH; Bachmann T; Baker KS; Balasegaram M; Bamford C; Baquero F; Barcelona LI; Bassat Q; Bassetti M; Basu S; Beardsley J; Vásquez GB; Berkley JA; Bhatnagar AK; Bielicki J; Bines J; Bongomin F; Bonomo RA; Bradley JS; Bradshaw C; Brett A; Brink A; Brown C; Brown J; Buising K; Carson C; Carvalho AC; Castagnola E; Cavaleri M; Cecchini M; Chabala C; Chaisson RE; Chakrabarti A; Chandler C; Chandy SJ; Charani E; Chen L; Chiara F; Chowdhary A; Chua A; Chuki P; Chun DR; Churchyard G; Cirillo D; Clack L; Coffin SE; Cohn J; Cole M; Conly J; Cooper B; Corso A; Cosgrove SE; Cox H; Daley CL; Darboe S; Darton T; Davies G; de Egea V; Dedeić-Ljubović A; Deeves M; Denkinger C; Dillon JAR; Dramowski A; Eley B, 2024, 'WHO global research priorities for antimicrobial resistance in human health', Lancet Microbe, 5, http://dx.doi.org/10.1016/S2666-5247(24)00134-4

van Hal SJ; Sherry N; Coombs G; Mowlaboccus S; Whiley DM; Lahra MM, 2024, 'Emergence of an extensively drug-resistant Neisseria gonorrhoeae clone', Lancet Infectious Diseases, 24, pp. e547 - e548, http://dx.doi.org/10.1016/S1473-3099(24)00486-9

Unemo M; Sánchez-Busó L; Golparian D; Jacobsson S; Shimuta K; Lan PT; Eyre DW; Cole M; Maatouk I; Wi T; Lahra MM, 2024, 'The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains-phenotypic, genetic and reference genome characterization', Journal of Antimicrobial Chemotherapy, 79, pp. 1885 - 1899, http://dx.doi.org/10.1093/jac/dkae176

Lahra MM; George RCR; van Hal SJ, 2024, 'Global, regional and local surveillance of antimicrobial resistance in Neisseria gonorrhoeae', Microbiology Australia, 45, pp. 138 - 141, http://dx.doi.org/10.1071/MA24038

Lan PT; Nguyen HT; Golparian D; Thuy Van NT; Maatouk I; Unemo M; Doanh LH; Hoa PQ; Hoa PD; Minh Phuong PT; Trang TM; Dieu Van TT; Nam PT; Ha Vinh NT; Ha Giang QT; Tung VT; Tuan ND; Phan Nguyen TT; Phuong Vu TT; Thanh Nguyen PT; Duong BH; Van Loi Doan E; Thuy Nguyen DT; Le KT; Bui TM; Pham NN; Kieu Nguyen TT; Thanh Phan TT; Quynh Dang AD; Khoa NT; Lahra M; McDonald R; Kreisel K; Wi T; Schröder D; Jacobsson S, 2024, 'The WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 2023', Lancet Regional Health Western Pacific, 48, http://dx.doi.org/10.1016/j.lanwpc.2024.101125

Ouk V; Say HL; Virak M; Deng S; Frankson R; McDonald R; Kersh EN; Wi T; Maatouk I; van Hal S; Lahra MM; Mom PK; Fensham V; Kreisel KM; Escher M; Izumi K; Nishijima T; Unemo M; Kundu RL; Ray S; Hogan TR, 2024, 'World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme, Cambodia, 2023', Emerging Infectious Diseases, 30, pp. 1493 - 1495, http://dx.doi.org/10.3201/eid3007.240354

Sotheran E; Lane CR; Horan K; Stevens K; Guglielmino C; Bradbury S; Kennedy K; Cooley L; McEwan B; Kahler CM; Mowlaboccus S; Speers DJ; Baird R; Freeman K; Leong L; Warner M; Williamson DA; McVernon J; Lahra M; Jennison AV; Howden BP; Andersson P, 2024, 'Genomic Surveillance of Invasive Meningococcal Disease During a National MenW Outbreak in Australia, 2017-2018', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae249

Lahra MM; van Hal S; Hogan TR, 2024, 'Australian Gonococcal Surveillance Programme, 1 October to 31 December 2023', Communicable Diseases Intelligence 2018, 48

Lahra MM; Krishnan PS; Hogan TR, 2024, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2023', Communicable Diseases Intelligence 2018, 48

Lahra MM; Krishnan PS, 2024, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2023', Communicable Diseases Intelligence, http://dx.doi.org/10.33321/cdi.2024.48.21

Lahra MM; Hogan TR, 2024, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2023', Communicable Diseases Intelligence 2018, 48

Lahra MM; Hogan TR, 2024, 'Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2023', Communicable Diseases Intelligence 2018, 48

Marshall H; Ward J; Wang B; Andraweera P; McMillan M; Flood L; Bell C; Sisnowski J; Krause V; Webby R; Childs E; Gunathilake M; Egoroff N; Leong L; Lawrence A; Baird R; Freeman K; Menouhos D; Whiley DM; Karnon J; Van Hal S; Lahra MM, 2024, 'Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-079144

O’grady K; Hong S; Putsathit P; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Levy A; Moore CV; Nimmo G; Prendergast L; Robson J; Speers DJ; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR, 2024, 'Defining the phylogenetics and resistome of the major Clostridioides difficile ribotypes circulating in Australia', Microbial Genomics, 10, http://dx.doi.org/10.1099/mgen.0.001232

Seib KL; Donovan B; Thng C; Lewis DA; McNulty A; Fairley CK; Yeung B; Jin F; Fraser D; Bavinton BR; Law M; Chen MY; Chow EPF; Whiley DM; Mackie B; Jennings MP; Jennison AV; Lahra MM; Grulich AE, 2024, 'Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection in men who have sex with men: the GoGoVax study protocol', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-081675

Lahra MM; Latham NH; Templeton DJ; Read P; Carmody C; Ryder N; Ellis SE; Madden EF; Parasuraman A; Wells J; Sheppeard V; Armstrong BH; Holland J; Pendle S; Sherry N; Leong L; Papanicolas L; Selvey CE; Van Hal SJ, 2024, 'Investigation and response to an outbreak of Neisseria meningitidis serogroup Y ST-1466 urogenital infections, Australia', Communicable Diseases Intelligence 2018, 48, http://dx.doi.org/10.33321/cdi.2024.48.20

Ouk V; Heng LS; Virak M; Deng S; Lahra MM; Frankson R; Kreisel K; McDonald R; Escher M; Unemo M; Wi T; Maatouk I; Mom PK; Fensham V; Kersh E; Cavailler P; Mundade Y; van Hal SJ; Kundu RL; Hogan TR; Whiley DM; Izumi K; Nishijima T, 2024, 'High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022-23: WHO Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP)', Jac Antimicrobial Resistance, 6, http://dx.doi.org/10.1093/jacamr/dlae053

O'Brien A; Hart J; Higgins A; Arthur I; Lee GH; Leung M; Kennedy K; Bradbury S; Foster S; Warren S; Korman TM; Abbott IJ; Heney C; Bletchley C; Warner M; Wells N; Wilson D; Varadhan H; Stevens R; Lahra M; Newton P; Maley M; van Hal S; Ingram PR, 2024, 'Nocardia species distribution and antimicrobial susceptibility within Australia', Internal Medicine Journal, 54, pp. 613 - 619, http://dx.doi.org/10.1111/imj.16234

Lahra MM; Van Hal S; Hogan TR, 2024, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2023', Communicable Diseases Intelligence 2018, 48, http://dx.doi.org/10.33321/cdi.2024.48.13

Lahra MM; Van Hal S; Hogan TR, 2024, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2023', Communicable Diseases Intelligence 2018, 48, http://dx.doi.org/10.33321/cdi.2024.48.12

Lahra MM; Van Hal S; Hogan TR, 2024, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2023', Communicable Diseases Intelligence 2018, 48, http://dx.doi.org/10.33321/cdi.2024.48.14

Lahra MM; Hogan TR, 2023, 'Meningococcal Surveillance Australia - Reporting period 1 January to 31 March 2023', Communicable Diseases Intelligence 2018, 47, http://dx.doi.org/10.33321/cdi.2023.47.59

Van Hal SJ; Whiley DM; Le T; Ray S; Kundu RL; Kerr E; Lahra MM, 2023, 'Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype', Journal of Antimicrobial Chemotherapy, 78, pp. 2203 - 2208, http://dx.doi.org/10.1093/jac/dkad221

Ouk V; Pham CD; Wi T; van Hal SJ; Lahra MM, 2023, 'The Enhanced Gonococcal Surveillance Programme, Cambodia', Lancet Infectious Diseases, 23, pp. e332 - e333, http://dx.doi.org/10.1016/S1473-3099(23)00479-6

Lahra MM; Van Hal S; Hogan TR, 2023, 'Australian Gonococcal Surveillance Programme Annual Report, 2022', Communicable Diseases Intelligence 2018, 47, http://dx.doi.org/10.33321/cdi.2023.47.45

Lahra MM; George CR; Van Hal S; Hogan TR, 2023, 'Australian Meningococcal Surveillance Programme Annual Report, 2022', Communicable Diseases Intelligence 2018, 47, http://dx.doi.org/10.33321/cdi.2023.47.44

George CRR; Lahra MM; Nguyen T; Gatus B, 2023, 'Disc Test for Detecting Staphylococcus aureus Strains Producing Type A and Type C b-Lactamases', Microbiology Spectrum, 11, http://dx.doi.org/10.1128/spectrum.00220-23

Whiley DM; Tickner JA; Kundu RL; Hogan TR; van Hal SJ; Lahra MM, 2023, 'Selection of Neisseria gonorrhoeae ceftriaxone resistance using doxycycline post-exposure prophylaxis', Lancet Infectious Diseases, 23, pp. e268 - e269, http://dx.doi.org/10.1016/S1473-3099(23)00359-6

Bell SFE; Ware RS; Lewis DA; Lahra MM; Whiley DM, 2023, 'Antimicrobial susceptibility assays for Neisseria gonorrhoeae: a proof-of-principle population-based retrospective analysis', Lancet Microbe, 4, pp. e544 - e551, http://dx.doi.org/10.1016/S2666-5247(23)00071-X

Lahra MM; Hurley S; Ray S; Hogan TR, 2023, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2022', Communicable Diseases Intelligence 2018, 47, http://dx.doi.org/10.33321/cdi.2023.47.28

Back to profile page